Thieme E-Books & E-Journals -
Zurück
Hamostaseologie 2024; 44(S 01): S37-S38
DOI: 10.1055/s-0044-1779110
Abstracts
Topics
T-07. Haemophilia and von Willebrand disease

Bleeding Outcomes in Participants with Factor VIII Activity<5 IU/dL post–gene transfer in GENEr8-1

J. Mahlangu
1   Hemophilia Comprehensive Care Center, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand and NHLS, Johannesburg, South Africa
,
M. Ozelo
2   School of Medical Sciences, University of Campinas, Hemocentro UNICAMP, Department of Internal Medicine, Campinas, Brazil
,
C. W. Tan
3   Royal Adelaide Hospital, Department of Haematology, Adelaide, Australia
4   University of Adelaide, Adelaide, Australia
,
A. Giermasz
5   Hemophilia Treatment Center, University of California Davis, Sacramento, USA
,
J.-D. Wang
6   Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital, Taichung, Taiwan
,
S. Harris
7   BioMarin Pharmaceutical Inc., Novato, USA
,
D. Osmond
7   BioMarin Pharmaceutical Inc., Novato, USA
,
H. Yu
7   BioMarin Pharmaceutical Inc., Novato, USA
,
T. Robinson
7   BioMarin Pharmaceutical Inc., Novato, USA
› Institutsangaben